![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
National Institute on Drug Abuse, National Institutes of Health/Department of Health and Human Services, Intramural Research Program, Cellular Neurobiology Branch (M.O., C.R.L.), Behavioral Neurobiology Branch (M.M.), and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health/Department of Health and Human Services, Laboratory of Molecular and Cellular Neurobiology, Bethesda, Maryland (L.Z., A.R.)
The effects of endogenous and synthetic cannabinoid receptor agonists, including 2-arachidonoylglycerol (2-AG), R-methanandamide, WIN55,212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenylcarbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], and CP 55,940 [1
,2
-(R)-5
]-(-)-5-(1,1-dimethyl)-2-[5-hydroxy-2-(3-hydroxypropyl) cyclohexyl-phenol], and the psychoactive constituent of marijuana,
9-tetrahydrocannabinol (
9-THC), on the function of homomeric
7-nicotinic acetylcholine (nACh) receptors expressed in Xenopus oocytes was investigated using the two-electrode voltage-clamp technique. The endogenous cannabinoid receptor ligands 2-AG and the metabolically stable analog of anandamide (arachidonylethanolamide), R-methanandamide, reversibly inhibited currents evoked with ACh (100 µM) in a concentration-dependent manner (IC50 values of 168 and 183 nM, respectively). In contrast, the synthetic cannabinoid receptor agonists CP 55,940, WIN55,212-2, and the phytochemical
9-THC did not alter
7-nACh receptor function. The inhibition of
7-mediated currents by 2-AG was found to be non-competitive and voltage-independent. Additional experiments using endocannabinoid metabolites suggested that arachidonic acid, but not ethanolamine or glycerol, could also inhibit the
7-nACh receptor function. Whereas the effects of arachidonic acid were also noncompetitive and voltage-independent, its potency was much lower than 2-AG and anandamide. Results of studies with chimeric
7-nACh-5-hydroxytryptamine (5-HT)3 receptors comprised of the amino-terminal domain of the
7-nACh receptor and the transmembrane and carboxyl-terminal domains of 5-HT3 receptors indicated that the site of interaction of the endocannabinoids with the
7-nAChR was not located on the N-terminal region of the receptor. These data indicate that cannabinoid receptor ligands that are produced in situ potently inhibit
7-nACh receptor function, whereas the synthetic cannabinoid ligands, and
9-THC, are without effect, or are relatively ineffective at inhibiting these receptors.
Address correspondence to: Dr. Murat Oz, National Institute on Drug Abuse/Intramural Research Program, Cellular Neurobiology Branch, 5500 Nathan Shock Dr., Baltimore, MD 21224. E-mail: moz{at}intra.nida.nih.gov
This article has been cited by other articles:
![]() |
U. Baranowska, M. Gothert, R. Rudz, and B. Malinowska Methanandamide Allosterically Inhibits in Vivo the Function of Peripheral Nicotinic Acetylcholine Receptors Containing the {alpha}7-Subunit J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 912 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Spivak, C. R. Lupica, and M. Oz The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schuel and L. J. Burkman A Tale of Two Cells: Endocannabinoid-Signaling Regulates Functions of Neurons and Sperm Biol Reprod, December 1, 2005; 73(6): 1078 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oz, S. N. Jackson, A. S. Woods, M. Morales, and L. Zhang Additive Effects of Endogenous Cannabinoid Anandamide and Ethanol on {alpha}7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1272 - 1280. [Abstract] [Full Text] [PDF] |
||||